X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-08 | VIR | Sato Vicki L | Dir | S - Sale | $22.59 | -17,935 | 1,327,324 | -1% | -$405,062 | ||||||
2023-03-03 | VIR | Friedl-Naderer Johanna | EVP, COO | S - Sale | $22.82 | -1,482 | 148,518 | -1% | -$33,819 | ||||||
2023-03-01 | VIR | Sigal Charles Elliott | Dir | P - Purchase | $22.73 | +2,500 | 19,779 | +14% | +$56,816 | ||||||
2023-02-23 | VIR | Horn Howard | CFO | S - Sale | $25.97 | -2,248 | 230,712 | -1% | -$58,387 | ||||||
D | 2023-02-23 | VIR | Hanly Ann M. | CTO | S - Sale+OE | $25.97 | -2,302 | 117,215 | -2% | -$59,790 | |||||
M | 2023-02-23 | VIR | Scangos George A | Pres, CEO | S - Sale | $24.53 | -27,750 | 5,759,638 | 0% | -$680,747 | |||||
D | 2023-02-23 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $25.97 | -2,878 | 198,320 | -1% | -$74,750 | |||||
D | 2023-02-23 | VIR | Rice Steven J. | Chief Administrative Officer | S - Sale+OE | $25.97 | -1,795 | 108,414 | -2% | -$46,622 | |||||
2023-02-21 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $28.43 | -74,477 | 18,319,938 | 0% | -$2,117,336 | ||||||
M | 2023-02-17 | VIR | Scangos George A | Pres, CEO | S - Sale | $27.23 | -27,750 | 376,169 | -7% | -$755,517 | |||||
2023-02-17 | VIR | Rice Steven J. | Chief Administrative Officer | S - Sale | $25.29 | -1,981 | 37,209 | -5% | -$50,096 | ||||||
2023-02-17 | VIR | Pang Phillip | Chief Medical Officer | S - Sale | $25.29 | -2,802 | 141,198 | -2% | -$70,857 | ||||||
2023-02-17 | VIR | Horn Howard | CFO | S - Sale | $25.29 | -2,424 | 232,960 | -1% | -$61,298 | ||||||
2023-02-15 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $26.75 | -38,964 | 18,394,415 | 0% | -$1,042,384 | ||||||
M | 2023-02-13 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $26.28 | -117,957 | 18,433,379 | -1% | -$3,099,693 | |||||
M | 2023-02-09 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $26.28 | -234,271 | 18,551,336 | -1% | -$6,156,029 | |||||
M | 2023-02-07 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $28.51 | -145,422 | 18,785,607 | -1% | -$4,146,549 | |||||
2023-02-08 | VIR | Sato Vicki L | Dir | S - Sale | $28.38 | -17,915 | 1,345,259 | -1% | -$508,343 | ||||||
M | 2023-02-03 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $30.21 | -114,035 | 18,931,029 | -1% | -$3,444,984 | |||||
M | 2023-02-01 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $29.42 | -148,635 | 19,045,064 | -1% | -$4,372,175 | |||||
M | 2023-01-30 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $29.46 | -152,813 | 19,193,699 | -1% | -$4,502,337 | |||||
2023-01-23 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $28.34 | -36,512 | 19,346,512 | 0% | -$1,034,707 | ||||||
D | 2023-01-24 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $30.00 | -30,000 | 144,000 | -17% | -$900,057 | |||||
M | 2023-01-19 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.13 | -214,197 | 19,383,024 | -1% | -$5,811,411 | |||||
M | 2023-01-17 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $26.28 | -190,839 | 19,597,221 | -1% | -$5,015,158 | |||||
M | 2023-01-12 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $26.58 | -211,678 | 19,788,060 | -1% | -$5,625,878 | |||||
M | 2023-01-10 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $26.32 | -149,640 | 19,999,738 | -1% | -$3,938,493 | |||||
2023-01-09 | VIR | Sato Vicki L | Dir | S - Sale | $25.83 | -17,915 | 1,363,174 | -1% | -$462,784 | ||||||
M | 2023-01-06 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $26.03 | -100,980 | 20,149,378 | 0% | -$2,628,972 | |||||
2023-01-05 | VIR | Sigal Charles Elliott | Dir | P - Purchase | $24.96 | +2,500 | 17,279 | +17% | +$62,396 | ||||||
M | 2023-01-03 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $25.57 | -9,177 | 20,250,358 | 0% | -$234,613 | |||||
M | 2023-01-03 | VIR | Sigal Charles Elliott | Dir | P - Purchase | $25.43 | +5,000 | 14,779 | +51% | +$127,129 | |||||
2022-12-29 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $25.55 | -44,169 | 20,259,535 | 0% | -$1,128,461 | ||||||
2022-12-27 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $25.59 | -6,850 | 20,303,704 | 0% | -$175,304 | ||||||
M | 2022-12-22 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $25.93 | -175,225 | 20,310,554 | -1% | -$4,543,514 | |||||
M | 2022-12-20 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $25.84 | -215,756 | 20,485,779 | -1% | -$5,575,585 | |||||
2022-12-08 | VIR | Sato Vicki L | Dir | S - Sale | $25.81 | -17,915 | 1,381,089 | -1% | -$462,366 | ||||||
M | 2022-12-02 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.45 | -97,293 | 20,701,535 | 0% | -$2,671,058 | |||||
M | 2022-11-30 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.77 | -212,329 | 20,798,828 | -1% | -$5,895,941 | |||||
M | 2022-11-28 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.42 | -109,115 | 21,011,157 | -1% | -$2,991,385 | |||||
M | 2022-11-23 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.27 | -56,993 | 21,120,272 | 0% | -$1,554,415 | |||||
2022-11-22 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.27 | -65,213 | 21,177,265 | 0% | -$1,778,195 | ||||||
M | 2022-11-18 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.21 | -25,979 | 21,242,478 | 0% | -$706,817 | |||||
M | 2022-11-16 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.41 | -210,031 | 21,268,457 | -1% | -$5,757,609 | |||||
M | 2022-11-14 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.61 | -137,973 | 21,478,488 | -1% | -$3,809,267 | |||||
M | 2022-11-09 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.31 | -287,736 | 21,616,461 | -1% | -$7,856,738 | |||||
M | 2022-11-07 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.26 | -182,083 | 21,904,197 | -1% | -$4,964,081 | |||||
2022-11-08 | VIR | Sato Vicki L | Dir | S - Sale | $27.38 | -17,915 | 1,399,004 | -1% | -$490,549 | ||||||
2022-10-10 | VIR | Sato Vicki L | Dir | S - Sale | $20.67 | -17,915 | 1,416,919 | -1% | -$370,278 | ||||||
2022-09-08 | VIR | Sato Vicki L | Dir | S - Sale | $21.90 | -17,915 | 1,434,834 | -1% | -$392,335 | ||||||
M | 2022-08-15 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $27.97 | -130,364 | 22,086,280 | -1% | -$3,645,758 | |||||
D | 2022-07-20 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $30.00 | -5,000 | 144,000 | -3% | -$150,000 | |||||
D | 2022-07-11 | VIR | Ramasastry Saira | Dir | S - Sale+OE | $30.00 | -5,000 | 8,092 | -38% | -$150,000 | |||||
2022-07-08 | VIR | Sato Vicki L | Dir | S - Sale | $29.06 | -17,915 | 1,470,664 | -1% | -$520,694 | ||||||
2022-06-21 | VIR | Pang Phillip | Chief Medical Officer | S - Sale | $24.89 | -4,991 | 144,000 | -3% | -$124,209 | ||||||
2022-06-08 | VIR | Sato Vicki L | Dir | S - Sale | $25.84 | -17,915 | 1,488,579 | -1% | -$462,976 | ||||||
D | 2022-05-24 | VIR | Sato Vicki L | Dir | S - Sale+OE | $23.82 | -3,374 | 1,506,494 | 0% | -$80,369 | |||||
D | 2022-05-24 | VIR | Ramasastry Saira | Dir | S - Sale+OE | $23.82 | -1,687 | 8,092 | -17% | -$40,184 | |||||
2022-05-09 | VIR | Sato Vicki L | Dir | S - Sale | $20.62 | -14,541 | 1,503,463 | -1% | -$299,835 | ||||||
2022-04-28 | VIR | Sato Vicki L | Dir | S - Sale | $20.90 | -17,915 | 1,518,004 | -1% | -$374,424 | ||||||
2022-03-30 | VIR | Hanly Ann M. | CTO | S - Sale | $26.24 | -2,627 | 81,485 | -3% | -$68,925 | ||||||
D | 2022-02-22 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $30.00 | -1,375 | 175,407 | -1% | -$41,250 | |||||
2022-02-17 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale | $31.93 | -2,293 | 105,407 | -2% | -$73,218 | ||||||
M | 2022-02-17 | VIR | Scangos George A | Pres, CEO | S - Sale | $31.11 | -27,750 | 5,704,138 | 0% | -$863,378 | |||||
2022-02-17 | VIR | Rice Steven J. | Chief Administrative Officer | S - Sale | $31.93 | -1,942 | 18,658 | -9% | -$62,010 | ||||||
2022-02-17 | VIR | Horn Howard | CFO | S - Sale | $31.93 | -2,393 | 200,384 | -1% | -$76,411 | ||||||
DM | 2022-02-16 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $31.69 | -8,009 | 89,768 | -8% | -$253,780 | |||||
D | 2022-02-08 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $33.94 | -1,375 | 107,700 | -1% | -$46,668 | |||||
D | 2022-02-02 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $34.52 | -5,000 | 92,777 | -5% | -$172,620 | |||||
D | 2022-01-25 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $32.46 | -1,375 | 107,700 | -1% | -$44,633 | |||||
D | 2022-01-19 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $35.06 | -5,000 | 92,777 | -5% | -$175,304 | |||||
2022-01-18 | VIR | Sato Vicki L | Dir | S - Sale | $37.39 | -15,173 | 1,535,919 | -1% | -$567,385 | ||||||
D | 2022-01-11 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $35.10 | -1,375 | 107,700 | -1% | -$48,263 | |||||
D | 2022-01-05 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $37.19 | -5,000 | 92,777 | -5% | -$185,956 | |||||
D | 2021-12-28 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $39.95 | -1,375 | 107,700 | -1% | -$54,931 | |||||
2021-12-20 | VIR | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $52.73 | -400,022 | 22,216,644 | -2% | -$21,093,160 | ||||||
2021-12-20 | VIR | Sato Vicki L | Dir | S - Sale | $54.53 | -15,174 | 1,551,092 | -1% | -$827,485 | ||||||
D | 2021-12-15 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $50.72 | -5,000 | 92,777 | -5% | -$253,608 | |||||
DM | 2021-12-14 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $48.63 | -4,125 | 107,700 | -4% | -$200,585 | |||||
2021-12-01 | VIR | Pang Phillip | Chief Medical Officer | S - Sale | $43.45 | -7,500 | 92,777 | -7% | -$325,841 | ||||||
D | 2021-11-30 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $49.60 | -15,125 | 107,700 | -12% | -$750,200 | |||||
D | 2021-11-30 | VIR | Rice Steven J. | Chief Administrative Officer | S - Sale+OE | $50.00 | -10,000 | 20,600 | -33% | -$500,000 | |||||
D | 2021-11-30 | VIR | Napolitano Janet | Dir | S - Sale+OE | $46.25 | -1,435 | 3,374 | -30% | -$66,369 | |||||
2021-11-29 | VIR | Hanly Ann M. | CTO | P - Purchase | $43.39 | +12 | 30,612 | 0% | +$500 | ||||||
2021-11-26 | VIR | Sato Vicki L | Dir | S - Sale | $36.80 | -15,174 | 1,566,266 | -1% | -$558,403 | ||||||
D | 2021-11-17 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $35.85 | -5,000 | 100,277 | -5% | -$179,255 | |||||
D | 2021-11-16 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $32.67 | -1,375 | 107,700 | -1% | -$44,921 | |||||
D | 2021-11-03 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $36.47 | -5,000 | 100,277 | -5% | -$182,331 | |||||
D | 2021-11-02 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $36.94 | -1,375 | 107,700 | -1% | -$50,793 | |||||
2021-10-20 | VIR | Pang Phillip | Chief Medical Officer | S - Sale | $39.65 | -4,000 | 100,277 | -4% | -$158,596 | ||||||
D | 2021-10-19 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $38.87 | -1,375 | 107,700 | -1% | -$53,446 | |||||
2021-10-19 | VIR | Sato Vicki L | Dir | S - Sale | $39.56 | -15,174 | 1,581,440 | -1% | -$600,314 | ||||||
2021-10-06 | VIR | Pang Phillip | Chief Medical Officer | S - Sale | $34.56 | -5,000 | 104,277 | -5% | -$172,781 | ||||||
D | 2021-10-05 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $33.75 | -1,375 | 107,700 | -1% | -$46,406 | |||||
D | 2021-09-21 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $50.00 | -4,125 | 99,700 | -4% | -$206,250 | |||||
2021-09-17 | VIR | Sato Vicki L | Dir | S - Sale | $52.48 | -15,174 | 1,596,614 | -1% | -$796,301 | ||||||
2021-09-15 | VIR | Pang Phillip | Chief Medical Officer | S - Sale | $49.69 | -5,000 | 104,277 | -5% | -$248,462 | ||||||
D | 2021-09-07 | VIR | Virgin Herbert | EVP, Research, CSO | S - Sale+OE | $49.67 | -4,125 | 99,700 | -4% | -$204,875 | |||||
D | 2021-09-01 | VIR | Pang Phillip | Chief Medical Officer | S - Sale+OE | $49.58 | -5,000 | 109,277 | -4% | -$247,879 | |||||
D | 2021-08-30 | VIR | Napolitano Janet | Dir | S - Sale+OE | $51.15 | -1,435 | 3,374 | -30% | -$73,400 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |